NIH Funding Opportunities (Notices, PA, RFA)

Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 48 min 18 sec ago
Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
Notice NOT-TR-21-017 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Request for Information (RFI): Screening for High Resolution Cryo-Electron Microscopy
Notice NOT-RM-21-012 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Key Dates for PA-18-623 "Tools to Enhance the Study of Prenatal and Pediatric Hydrocephalus (R21 Clinical Trial Not Allowed)"
Notice NOT-NS-21-028 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Key Dates for PA-18-622 "Disease Mechanisms of Prenatal and Pediatric Hydrocephalus (R01 Clinical Trial Not Allowed)"
Notice NOT-NS-21-027 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Reminder Requesting Extensions for Early Career Scientists Whose Career Trajectories Have Been Significantly Impacted by COVID-19
Notice NOT-OD-21-052 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Human Milk as a Biological System (R01 Clinical Trial Optional)
Notice NOT-HD-21-005 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-22-004 from the NIH Guide for Grants and Contracts. This broad PAR will support exploratory studies addressing mechanistic questions in HIV infection, replication, latency, and/or pathogenesis (including HAND) in the context of SUDs.
Categories: Job Watch, Literature Watch
Limited Competition for the Continuation of Multisite Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Optional)
Funding Opportunity PAR-21-116 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), utilizing the U24 grant funding mechanism, encourages applications for competing renewal of Data Coordinating Center (DCC) for ongoing clinical trials supported by NCCIH. Extension of an ongoing clinical trial will be supported when there is need for additional time to complete the trial or when an extended period of follow up is well justified to assess longer term outcomes. The DCC competing renewal application must propose a comprehensive plan for completion of the clinical trial data collection that provides overall project coordination and administrative; data management; and biostatistical support for the ongoing clinical trial. Both a DCC application and a corresponding Clinical Coordinating Center application can be submitted simultaneously for consideration by NCCIH if both are needed to complete the ongoing. If clinical trial data collection and follow up can be completed centrally by the DCC and no study visits at clinical sites are needed, a single application for competing renewal for the DCC can be submitted. Applicants are strongly encouraged to contact the appropriate Scientific/Research contact for the ongoing clinical trial for which they are planning a competing renewal application prior to submitting to this FOA.
Categories: Job Watch, Literature Watch
Limited Competition for the Continuation or Revision of Multisite Clinical Trial Clinical Coordinating Center (Collaborative UH3 Clinical Trial Optional)
Funding Opportunity PAR-21-117 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for competing renewal of Clinical Coordinating Center (CCC) for ongoing clinical trials supported by NCCIH; or competitive revisions to support ancillary studies to ongoing NCCIH supported clinical trials. Extension of an ongoing clinical trial will be supported when there is need for additional time to complete the trial or when an extended period of follow up is well justified to assess longer term outcomes. Competitive revisions will be supported when there is compelling justification for the addition of an ancillary study to an ongoing clinical trial. The objective of the Clinical Coordinating Center is to provide the design scientific rationale and a comprehensive scientific and operational plan for the clinical trial. The Clinical Coordinating Center is expected to be responsible for project management, participant recruitment and retention strategies, performance milestones, scientific conduct, and dissemination of results. Both a DCC application and a corresponding Clinical Coordinating Center application should be submitted simultaneously for consideration by NCCIH if both are needed to complete the ongoing clinical trial. Applicants are strongly encouraged to contact the appropriate Scientific/Research contact for the ongoing clinical trial for which they are planning a competing renewal application or competitive revision prior to submitting to this FOA.
Categories: Job Watch, Literature Watch
Notice of Correction to PAR-20-256: Clarification on Frequency of Usage Reports
Notice NOT-OD-21-048 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Request for Information on the 2021-2026 National Institute of Neurological Disorders and Stroke Strategic Plan
Notice NOT-NS-21-021 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Key Dates of PAR-20-286, "Practice-Based Suicide Prevention Research Centers (P50 Clinical Trial Optional)"
Notice NOT-MH-21-160 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed)
Funding Opportunity PAR-21-145 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites research projects that seek to model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health, illness, recovery, and overall wellbeing. Both animal and human subjects research projects are welcome. Researchers proposing basic science experimental studies involving human participants should consider this FOAs companion for basic experimental studies with humans.
Categories: Job Watch, Literature Watch
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required)
Funding Opportunity PAR-21-144 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites research projects that seek to explain the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in human health, illness, recovery, and overall wellbeing. Types of projects submitted under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical and/or behavioral outcomes in humans to understand fundamental aspects of phenomena related to social connectedness and isolatedness. NIH considers such studies as prospective basic science studies involving human participants that meet the NIH definition of basic research and fall within the NIH definition of clinical trials (see, e.g., NOT-OD-19-024) Types of studies that should submit under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind.
Categories: Job Watch, Literature Watch
Notice of Change to RFA-DA-21-016, "Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R43/R44 - Clinical Trials Optional)"
Notice NOT-DA-21-057 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NIAID's Participation in PAR-19-039: Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)
Notice NOT-AI-21-026 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NIAID's Participation in PAR-20-316: NIH Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 - Clinical Trial Optional)
Notice NOT-AI-21-029 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NIAID's Participation in PAR-20-253: Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed)
Notice NOT-AI-21-028 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NIAID's Participation in PAR-19-040: Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)
Notice NOT-AI-21-027 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Gender Inclusive Excellence (AGIE) Coordinating Center (U54)
Notice NOT-OD-21-051 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch